Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Immunity Group Australia is a Biotechnology Research brand in Sydney, NSW. It is privately held, and its site is immunitygroupaustralia.com. It holds one address on record, all in Australia. Headcount on record is 3. Its work is tagged gut health and immunology. Three Australian registrations (ABN) are candidate matches. It is listed alongside four similar brands, mostly in Non-profit Organizations.
ABN95104821892
ABN23104435145
ABN11006720752
| IMMUNITY AUSTRALIA PTY LTD | ABN 95104821892 |
|---|---|
| IMMUNITY CORPORATION PTY LTD | ABN 23104435145 |
| IMMUNITY PTY. LTD. | ABN 11006720752 |
| Confirmed matches | 0 of 3 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
We are a translational U.S.-Australian biotech company, with a special interest in food allergy diagnostics, microbiome health and R&D. Our co-founders are Dr Douglas H Jones MD, American Board-certified allergist and immunologist (FAAAAI, FACAAI, USA) and Dr Nina Markovic Khaze (PhD), a specialist researcher and entrepreneur from Sydney.
Dr. Jones is a world-renowned and American Board-certified allergologist and immunologist, specialising in allergy, asthma, and immunology. He is co-founder and current President of a non-profit organization, Food Allergy Support Team (FAST), and co-founder of a Global Food Therapy training course for medical practitioners specialising in oral immunotherapy for allergies. He advocates for other rare diseases such as primary immunodeficiency disorders and hereditary angioedema.
Dr. Jones has received numerous awards, including: Utah's best allergist (Salt Lake City Weekly), Who’s Who Top Doctors Honors Edition, Most Compassionate Doctor, Hereditary Angioedema (HAE) Allies Award Winner, America’s Top Physicians, and Patient’s Choice Award. Dr Jones has been published internationally and widely cited.
Dr Nina Markovic Khaze is an academic affiliated with Macquarie University, with a special interest in advancing U.S.-Australia alliance relationship through biomedical research and development (R&D). She is a member of AusBiotech, Australia's peak industry body linking Australian companies with their overseas counterparts in the global life sciences sector. She is also a journalist with SBS and background in food allergies research. Her special interests in biotech sector include microbiome translational research and new product development.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
Three Australian entities on the ABR: IMMUNITY AUSTRALIA PTY LTD (ABN 95 104 821 892), IMMUNITY CORPORATION PTY LTD (ABN 23 104 435 145) and IMMUNITY PTY. LTD. (ABN 11 006 720 752). All medium confidence.
3 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Sydney, NSW 2000.
None linked to this brand.
Six tags on the brand's own list, among them gut health and immunology.
2 profiles list Immunity Group Australia as a peer — 42nd percentile in Biotechnology Research. It lists ten peers of its own. ausEE Inc. and Allergy Microbiome Foundation list it back.